SEB Företagsinvest, 3i and company's management acquire SBL Vaccin
SEB Företagsinvest, 3i and company's management acquire SBL Vaccin · SBL executive management personnel, in cooperation with the 3i Group plc and SEB Företagsinvest, have acquired SBL Vaccin AB (SBL) from Chiron Vaccines, a business unit of the US-based Chiron Corporations Inc. · SBL develops, manufactures, markets and distributes vaccines. The company's products include Dukoral®, an oral vaccine that provides protection against cholera. It is also used to prevent so-called travelers' diarrhoea. · Dukoral® has been successfully sold in Sweden and Norway for several years and was recently